Supercharged donor cells aim to prevent cancer relapse after transplant
NCT ID NCT05473910
First seen Apr 11, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This early-phase study tests whether specially engineered donor immune cells (TSC-100 or TSC-101) can safely reduce the risk of cancer returning in adults with acute myeloid leukemia, myelodysplastic syndromes, or acute lymphoblastic leukemia after a stem cell transplant. About 75 participants will receive either the engineered cells or standard care. The main goals are to check safety and see if the treatment improves how long people stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor University Medical Center
RECRUITINGDallas, Texas, 75246, United States
Contact
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
-
Columbia University
RECRUITINGNew York, New York, 10027, United States
Contact
-
Froedert and Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
-
John Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
Contact
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Mass General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
-
Memorial Healthcare System
RECRUITINGHollywood, Florida, 33021, United States
Contact
-
Mount Sinai
RECRUITINGNew York, New York, 10029-6696, United States
Contact
-
Northside Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
Contact
-
UPenn
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
-
University North Carolina
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact
-
Yale
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
Explore the condition pages connected to this study.